Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational Accepts healthy volunteers

PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study

ClinicalTrials.gov ID: NCT02250313

Public ClinicalTrials.gov record NCT02250313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main hypothesis of this study is to demonstrate that the use of the ConfirmMDx for Prostate Cancer test in previously biopsied patients improves urologists' patient management by reducing unnecessary repeat biopsies, attendant procedure costs, and potential adverse events in men being considered for a repeat procedure.

Study identification

NCT ID
NCT02250313
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
MDx Health
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Actual)
Primary completion
Jul 2018 (Actual)
Completion
Jul 2018 (Actual)
Last update posted
Jul 26, 2018

2014 – 2018

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209 —
Genesis Research LLC San Diego California 92123 —
Skyline Urology Torrance California 90505 —
Urology Center of Colorado Denver Colorado 80211 —
First Urology, PSC Jeffersonville Indiana 47130 —
Regional Urology, LLC Shreveport Louisiana 71106 —
Chesapeake Urology Research Associates Towson Maryland 21204 —
Michigan Institute of Urology Troy Michigan 48084 —
Associated Medical Professionals of NY Syracuse New York 13210 —
Oregon Urology Institute Springfield Oregon 97477 —
Lancaster Urology Lancaster Pennsylvania 17604 —
Carolina Urological Research Center Myrtle Beach South Carolina 29572 —
Urology Associates, P.C. Nashville Tennessee 37209 —
Urology Clinics of North Texas, PLLC Dallas Texas 75231 —
Urology San Antonio Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02250313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02250313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →